Search results for: 'Engineered Antibody Therapeutics for Cancer'
- Did you mean
- engineered antibodi therapeutics for cancer
- Related search terms
- forecasting the global imaging market for 2026
- Forecasting the Global Imaging Market for 2016
- forecasting the global imaging market for 2024®ions=235
- forces managed security services market study
- Antibody Drug Conjugate (ADC) Therapeutics Market, Global, 2026–2031
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
21 Dec 2022  |  Global  |  Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
20 Mar 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell-based Liver Therapy, Bacteriophage Therapeutics, Cell & Gene Therapy, and Small Molecule Therapeutics
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...
$950.00 -
08 Jul 2026  |  Global  |  Technology Research
Digital Therapeutics for Chronic Conditions
From Apps to Digital Interventions to Clinically-Regulated Prescription Digital Therapeutics
This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...
$4,950.00 -
27 Apr 2023  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 Dec 2025  |  Global  |  Technology Research
Growth Opportunities in Cancer Treatment Technologies, 2025–2029
Radiation and Non-radiation Therapies to Drive Transformational Growth in Cancer Management
Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.The growing burden of cancer cases globally—primar...
$4,950.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
17 Sep 2025  |  Global  |  Market Research
Innovations in Global Multiomics Technologies for Cancer
Global Trends, Technological Breakthroughs, and Collaborative Pathways Transforming Cancer Care
This study examines how global multiomics technologies are changing the way that cancer is treated, with a focus on new developments, strategic needs, and future directions. By facilitating thorough tumor characterization, early detection, patient stratification, and real-time monitoring, multiomics—an integrated analysis of genomics, transcriptomi...
$4,950.00